BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 15/01/2021

FDA Publishes Transparency on Drug Review Timeline Policy

The US Food and Drug Administration (FDA) has released a statement outlining its policy on transparency regarding the review timeline for new drug submissions, aiming to increase public awareness and trust in the agency's decision-making process.

Source: Federal Register — Food and Drug AdministrationOpen original release →